LFWD Earnings Date & History
Lifeward Ltd (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:35 PM ET
Lifeward Ltd
Health Care
- Next earnings date
- Thursday, November 12, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-1.01
- Revenue estimate
- $8.7M
LFWD earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Friday, August 14, 2026 | Q2 2026 | $-1.37 | $-1.46 | -6.8% | $6.6M |
| Friday, May 15, 2026 | Q1 2026 | $-1.28 | $-3.13 | -144.5% | $3.9M |
| Wednesday, March 18, 2026 | Q4 2025 | $-1.10 | $-3.60 | -226.8% | $5.1M |
| Friday, November 14, 2025 | Q3 2025 | $-2.63 | $-2.40 | +8.8% | $6.2M |
| Thursday, August 14, 2025 | Q2 2025 | $-3.73 | $-6.96 | -86.4% | $5.7M |
What the market is watching in LFWD's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next LFWD earnings date?
- Lifeward Ltd is scheduled to report on Thursday, November 12, 2026 (Time TBD). Dates can change until the company confirms them.
- Does LFWD report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for LFWD?
- Consensus EPS for the upcoming quarter is $-1.01, on revenue of $8.7M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
LFWD earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.